RNA Analysis / Global Market Report 2021

DublinAnd November 10, 2021 /PRNewswire/ – Market growth and reach $8.62 billion In 2025 according to “RNA Analysis / 2021 Global Market Report: Growth and Change of COVID-19” Report added to ResearchAndMarkets.com an offer.

Research and Markets logo

This report provides strategists, marketers, and top management with the critical information they need to evaluate the global RNA/Transcription Analysis market.

The global RNA analysis / transcription market is expected to grow from $4.59 billion In 2020 to 5.22 billion dollars in 2021 with a compound annual growth rate (CAGR) of 13.8%. The growth is mainly due to companies rearranging their operations and recovering from the impact of COVID-19, which earlier led to restrictive containment measures including social distancing, remote working and closing of businesses which led to operational challenges. It is expected to reach the market $8.62 billion in 2025 at a compound annual growth rate of 13.4%.

The report focuses on the RNA/Transcription Analysis Market which is experiencing robust growth. It gives a guide to the RNA/transcriptomics analysis market that will shape and change our lives over the next ten years and beyond, including the market’s response to the challenge of a global pandemic.

Reasons to buy

  • Get a true global perspective with the most comprehensive report available on this market covering over 12 geographies.

  • Understand how the market is affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus wears off.

  • Create regional and country strategies based on local data and analyses.

  • Identify growth sectors for investment.

  • Outperform competitors with forecasting data, drivers, and trends shaping the market.

  • Understand customers based on the latest market research findings.

  • Measuring performance against major competitors.

  • Leverage relationships between major data sets for superior strategic planning.

  • Suitable for supporting your internal and external presentations with reliable, high-quality data and analytics

Where is the largest and fastest growing market for RNA/transcriptomics analysis? How does the market relate to macroeconomics, demography, and other similar markets? What forces will shape the market in the future? The global RNA/Transcriptomics Analysis Market report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. Tracks historical and forecast market growth by geography. It places the market in the context of the broader RNA analysis/transcriptomics market, and compares it to other markets.

  • The Market Characteristics section of the report identifies and explains the market.

  • The Market Size section gives the market size (in USD) covering both the historical growth of the market, the impact of COVID-19 virus and its growth forecast.

  • Market segmentation divides the market into sub-markets.

  • The regional and country segmentation section provides an analysis of the market in each geographic region and the market size by geographic region and compares its historical and projected growth. It covers the COVID-19 growth trajectory for all regions, major developed countries and major emerging markets.

  • The competitive landscape gives a description of the competitive nature of the market, market shares and a description of the leading companies. The major financial deals that have shaped the market in recent years have been identified.

  • The Trends and Strategies section analyzes what the market will look like as it emerges from the crisis and suggests how companies can grow as the market recovers.

  • The RNA/transcriptomics market analysis section of the report gives context. The RNA/transcriptomics analysis market compares with other segments of the RNA/transcriptomics analysis market by volume, growth, historical and forecast. Analyzes the percentage of GDP, expenditure per capita, RNA analysis / comparison of transcription indices.

The major players in the RNA/transcriptomics analysis market are Affymetrix Inc. and Agilent Technologies Inc. and Bio-Rad Laboratories Inc. and GE Healthcare and Illumina Inc. and Qiagen NV and F. Hoffmann-La Roche Ltd. and Sigma-Aldrich Corporation and Thermo Fisher Scientific Inc. and Fluidigm Corporation, Promega Corporation, and Biomereiux SA.

The RNA/transcriptomics analysis market consists of sales of RNA analysis products and related services by entities (organizations, sole traders, partnerships) that provide RNA analysis. Transcript/RNA analysis is the study of transcription under specific conditions or environment or in a particular cell using high-throughput methods.

The main types of products in the RNA/transcriptomics analysis market are reagents/consumables, tools, and software. It is implemented in various fields including clinical diagnosis, drug discovery, toxicological genomics, comparative transcriptomics, and RNA interference. The main technologies involved in RNA/transcriptomics analysis are microarrays, sequencing, polymerase chain reaction, RNA interference. RNA analysis is used in clinical diagnosis to detect different types of RNA, pathogenic RNA splice variants among others useful in the diagnosis of diseases.

North Amarica It was the largest region in RNA/transcriptomics analysis market in 2020. This region is expected to be the fastest growing region in the forecast period. The areas covered in this report are Asia PacificAnd Western EuropeAnd Eastern EuropeAnd North AmaricaAnd South AmericaAnd Middle east, And Africa.

Technological developments and innovations in RNA analysis is an emerging trend in the RNA/transcription analysis market. Technologies such as next-generation sequencing (NGS) and RNA interference (RNAi) are improving accuracy and precision, helping researchers analyze transcriptional activity. For example, next-generation sequencing developed by Illumina is successfully used to fragment DNA/RNA into multiple fragments, add adapters, sequence libraries, and recombine them to form genetic sequences.

in a October 2020, 10x Genomics, a startup company based in United States of America Acquired Kartana for $ $41.2 million. The acquisition of Kartana is expected to further its approach to developing technologically advanced products. Kartana is a SwedenBiotech player based on the development of in situ RNA analysis technology.

The increasing demand for personalized medicine is expected to lead to the growth of the RNA/Transcription Analysis market in the coming years. Personalized medicine refers to personalizing medical treatment according to the unique characteristics of each patient. If scientists can implement the practices and processes needed for personalized clinical care, RNA-Seq will be well positioned to handle the massive clinical workload. According to a report on personalized drugs by the US Food and Drug Administration, 11 of the 44 new drugs approved in 2019 were designated drugs. Moreover, according to the Personalized Medicine 2020 Report published by the Personalized Medicine Alliance (PMC), the number of personalized medicines on the market doubled between 2016 and 2020 in United States of America. Therefore, the increasing demand for personalized medicine is driving the growth of the RNA Analysis market.

Countries covered in the RNA/Transcriptomics Analysis market report are AustraliaAnd BrazilAnd ChinaAnd FranceAnd GermanyAnd IndiaAnd IndonesiaAnd JapanAnd RussiaAnd South Korea, United kingdom, United States of America.

Main topics covered:

1. Executive Summary

2. RNA Analysis / Transcriptomics Market Characteristics

3. RNA Analysis / Market Trends & Strategies

4. Impact of COVID-19 on RNA/Transcriptomics Analysis

5. RNA Analysis/Market Size & Growth
5.1 Global RNA Transcriptase Analysis/Historical Market, 2015-2020, Billion Dollars
5.1.1. market drivers
5.1.2. Market Restrictions
5.2 Global RNA Analysis / Market Forecast, 2020-2025F, 2030F, Billion Dollars
5.2.1. market drivers
5.2.2. Market Restrictions

6. RNA Analysis / Transcriptomics Market Segmentation
6.1 Global RNA Transcriptase Market Analysis, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
6.2 Global DNA Transcription Market Analysis, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion Dollars
6.3 Global RNA Transcriptase Market Analysis, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7. RNA Analysis / Regional and Country Market Analysis
7.1 Global DNA Transcriptase Market Analysis, By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion Dollars
7.2 Global DNA Transcriptase Market Analysis, Segmented by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion Dollars

For more information about this report visit https://www.researchandmarkets.com/r/n4atzf

Media contact:

Research and Markets
Laura Wood, director, mentor
[email protected]

For EST office hours, call +1-917-300-0470
For US/Canada, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US Fax: 607-646-1907
Fax (outside the US): +353-1-481-1716

Cision

Cision

View original content:https://www.prnewswire.com/news-releases/rna-analysis-transcriptomics-global-market-report-2021-301420979.html

SOURCE Research & Markets

Write a Comment

Your email address will not be published. Required fields are marked *